Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Not applicable Interventional

Is Splinting After Ulnar Nerve Transposition Necessary?

ClinicalTrials.gov ID: NCT07880470

Public ClinicalTrials.gov record NCT07880470. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical trial is to learn whether patient recovery after ulnar nerve transposition (UNT) requires a splint. The main questions it aims to answer are: * Does the effect that early versus delayed mobilization after UNT have on patient sleep quality differ? * What are the medical complications, reoperations, and timeline of returning to work that result from this procedure like? Participants will be placed in a stiff splint (that limits elbow movement) or no splint (that allows for earlier elbow movement) after this surgery. Participants will report their recovery through surveys measuring physical function, pain, and sleep. Researchers will compare the results between the two types of splinting.

Study identification

NCT ID
NCT07880470
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
University of Chicago
Other
Enrollment
50 participants

Conditions and interventions

Interventions

Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2026 (Estimated)
Primary completion
Feb 2028 (Estimated)
Completion
Feb 2028 (Estimated)
Last update posted
Oct 19, 2026

2026 – 2028

United States locations

U.S. sites
5
U.S. states
2
U.S. cities
5
Facility City State ZIP Site status
UChicago Medicine at Ingalls - Calumet City Calumet City Illinois 60409 —
University of Chicago Medical Center Hyde Park Illinois 60637 —
UChicago Medicine Orland Park Orland Park Illinois 60462 —
UChicago Medicine at Ingalls - Tinley Park Tinley Park Illinois 60477 —
UChicago Medicine Crown Point Crown Point Indiana 46307 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07880470, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07880470 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →